Our business at a glance Our proven business model helps us to deliver on our mission of enabling people with life-altering conditions to lead better lives, through leading the way in our chosen specialist areas.
ADHD Ulcerative colitis We have a balanced Specialty portfolio of differentiated Pharmaceuticals ADHD Ulcerative colitis products that have many years of growth still ahead, We focus on small-molecule medications Chronic constipation within the therapeutic areas of Behavioral ADHD as well as the potential Health, where we maintain a leadership to expand into further position, and Gastro Intestinal disease, ADHD Essential thrombocythaemia among others.
Patients are at the heart of our business Ulcerative colitis Renal disease and we are increasingly engaging with a broader range of stakeholders to ensure that we develop innovative products that payors and policymakers around the world Fabry disease will welcome as they deliver value to the Human Genetic healthcare system.
Therapies Hunter syndrome Through our deep understanding of patients needs, we develop and provide This business is solely focused on healthcare in the areas of: researching, developing and marketing Gaucher disease novel products and services that Q Behavioral Health and profoundly enhance the quality of Gastro Intestinal conditions Hereditary angioedema life of patients suffering from rare Q Rare Genetic Diseases genetic diseases.
Q Regenerative Medicine Diabetic foot ulcers Regenerative Medicine A leader in providing regenerative medicine solutions for people with lifealtering conditions.
We aspire to harness the power of regenerative medicine to address societys unmet medical needs, and are focused on developing and delivering solutions that support the bodys natural healing process.
8 Shire plc Annual Report 2012 Overview Our people continue to carry forward many More online at: Where we operate of the original attributes of the Companys http: ar2012.
com With major operations in the US, UK, founders opportunistic thinking, Ireland and Switzerland, and a network of transparent behavior, a deep commitment ofces and distribution channels to doing what is right, and a prevailing throughout Europe, South America, concern for the patients and caregivers Canada, and the Pacic Rim, we employ served by the Companys well differentiated over 5,300 people in 29 countries.
Basingstoke UK Dublin La Jolla, Ireland San Diego California USA Lexington, Boston Nyon, Wayne Massachusetts Geneva Pennsylvania USA Switzerland USA So Paulo Brazil Net product sales by geographic region Number of employees by geographic region 1 US 67% 1 US 67% 4 2 Europe 22% 3 2 UK 10% 5 3 Latin America 4% 3 Switzerland 4% 4 4 Other 7% 4 Ireland 2% 2 3 5 All Other Geographies 17% 1 2 1 Product sales People Number of countries $4.4BN 5,300 29 Shire plc Annual Report 2012 9
